Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 40.96B | 41.98B | 41.36B | 38.63B | 37.24B | 32.54B |
Gross Profit | 12.38B | 12.65B | 13.16B | 12.24B | 11.22B | 9.95B |
EBITDA | 2.93B | 3.67B | 3.96B | 3.91B | 4.27B | 3.20B |
Net Income | 1.48B | 1.20B | 1.48B | 1.67B | 2.19B | 1.53B |
Balance Sheet | ||||||
Total Assets | 46.07B | 47.01B | 47.83B | 43.63B | 40.54B | 37.68B |
Cash, Cash Equivalents and Short-Term Investments | 7.23B | 6.53B | 8.88B | 6.60B | 6.66B | 5.63B |
Total Debt | 9.27B | 9.62B | 11.42B | 9.14B | 8.60B | 8.55B |
Total Liabilities | 20.54B | 20.88B | 22.51B | 19.04B | 17.37B | 16.55B |
Stockholders Equity | 24.89B | 25.44B | 24.73B | 23.73B | 22.34B | 20.37B |
Cash Flow | ||||||
Free Cash Flow | -45.76M | 1.12B | 1.42B | 110.17M | 1.46B | -202.23M |
Operating Cash Flow | 85.64M | 1.71B | 2.62B | 1.68B | 2.74B | 836.88M |
Investing Cash Flow | -1.01B | -410.03M | -1.44B | -1.69B | -1.15B | -2.21B |
Financing Cash Flow | -1.06B | -3.38B | 808.50M | -517.24M | -900.07M | 685.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥18.38B | 15.66 | 4.99% | 1.50% | -18.81% | ||
80 Outperform | ¥13.33B | 7.52 | 3.07% | -1.59% | -6.38% | ||
78 Outperform | ¥38.13B | 14.97 | 0.83% | -15.98% | -51.13% | ||
74 Outperform | €153.78B | 8.61 | 10.70% | 3.93% | 0.94% | -16.06% | |
72 Outperform | ¥26.68B | 6.25 | 7.91% | -10.85% | 25.59% | ||
70 Outperform | ¥18.20B | 4.98 | 4.66% | 21.35% | 221.66% | ||
63 Neutral | $34.07B | 6.13 | -11.73% | 1.80% | 5.33% | -18.31% |